{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:36:15Z","timestamp":1790796975298,"version":"4.1.0"},"reference-count":27,"publisher":"Korean Cancer Association","content-domain":{"domain":["e-crt.org"],"crossmark-restriction":true},"short-container-title":["Cancer Res Treat"],"DOI":"10.4143\/crt.2025.820","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:46:12Z","timestamp":1762242372000},"update-policy":"https:\/\/doi.org\/10.4143\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors"],"prefix":"10.4143","author":[{"given":"Jin Seok","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Yong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Oh","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SuYeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwi-yeol","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Young","family":"Ock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woochan","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yeong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2954","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.08.065"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030655"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32160"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.07.062"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1305569110"},{"key":"ref6","first-page":"286","volume":"138","author":"Majeti","year":"2009","journal-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40241-1"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00373-5"},{"key":"ref9","first-page":"946","volume":"37","author":"Sikic","year":"2019","journal-title":"First-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-sitc2020.0385"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1807315"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000413"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-sitc2020.0218"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2020.1779974"},{"key":"ref15","first-page":"4789","volume":"85","author":"Choi","year":"2025","journal-title":"Development of IMC-002, a next-generation anti-CD47 mAb: an affinity optimized antibody with enhanced safety and therapeutic efficacy in preclinical models"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00770-z"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/his.15176"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013277"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.02604"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00821-1"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-20-2085"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01341-0"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1378647"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(21)00584-2"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-20-3706"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.1883"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02989-2"}],"container-title":["Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-crt.org\/upload\/pdf\/crt-2025-820.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:39:03Z","timestamp":1782293943000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-crt.org\/journal\/view.php?doi=10.4143\/crt.2025.820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":27,"URL":"https:\/\/doi.org\/10.4143\/crt.2025.820","relation":{},"ISSN":["1598-2998","2005-9256"],"issn-type":[{"value":"1598-2998","type":"print"},{"value":"2005-9256","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"2025-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-04","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}}]}}